RDHL


RedHill Biopharma Ltd – ADR (RDHL) Shares Pop on Positive Clinical Outcome in Acute Gastroenteritis

RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) released positive top-line results from the Phase III GUARD study with BEKINDA® (RHB-102) 24 mg for acute …

Roth Capital Maintains Buy On RedHill Following 2015 Outlook

In a research report released today, Roth Capital analyst Scott Henry reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) with a $27.50 price …

Roth Capital Highlights RedHill As A Company To Watch In 2015; Raises PT To $27.50

In a research report issued today, Roth Capital analyst Scott Henry reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) and raised his price …

We Are Looking For An Eventful 2015 For RedHill Biopharma, Says MLV

MLV analyst Vernon Bernardino is out with a research report on RedHill Biopharma (NASDAQ:RDHL), reiterating a Buy rating and a $25 price target, which represents a potential …

MLV Cuts RedHill Price Target To Reflect A Delay In Rizaport Approval

In a research report issued today, MLV analyst Vernon Bernardino reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) but slightly reduced his price target …

RedHill’s Enterprise Value Of ~$100 Million Underestimates The Breadth Of Its Pipeline, Says Roth Capital

In a research report issued today, Roth Capital analyst Scott Henry maintained a Buy rating on RedHill Biopharma (NASDAQ:RDHL), with a price target of …

Roth Capital Maintains Buy On RedHill, Boosts Price Target To $24

In a research note issued this morning, Roth Capital analyst Scott Henry maintained a Buy rating on RedHill Biopharma (RDHL) and raised his price target …